Haris Zahoor

Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma

Ahmad A. Tarhini, Haris Zahoor, Yan Lin et al. · Journal for ImmunoTherapy of Cancer · 2015 · 390 citations · Full text

Life Sciences, Immunology, Oncology +17

CT-based radiomics stratification of tumor grade and TNM stage of clear cell renal cell carcinoma

Natalie L. Demirjian, Bino Varghese, Steven Cen et al. · European Radiology · 2021 · 102 citations

Medicine, Oncology, Radiology +17

Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab

Haris Zahoor, Pedro C. Barata, Xuefei Jia et al. · Journal for ImmunoTherapy of Cancer · 2018 · 67 citations · Full text

Medicine, Oncology, Genitourinary Oncology +16

Mast Cell Proteases Activate Astrocytes and Glia-Neurons and Release Interleukin-33 by Activating p38 and ERK1/2 MAPKs and NF-κB

Duraisamy Kempuraj, Ramasamy Thangavel, Govindhasamy Pushpavathi Selvakumar et al. · Molecular Neurobiology · 2018 · 62 citations

Life Sciences, Neurobiology, Neuroscience +16

Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer

Haris Zahoor, M.C. Mir, Pedro C. Barata et al. · Investigational New Drugs · 2019 · 38 citations

Medicine, Oncology, Pharmacology +13